Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration

Nicotine and Tobacco Research

Volumn 7, Issue 6, 2005, Pages 901-907

  Rauhut, Anthony S ^a   Dwoskin, Linda P ^b   Bardo, Michael T ^c  

^a DICKINSON COLLEGE   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG PELLET; DRUG RESPONSE; DRUG SELF ADMINISTRATION; DRUG SPECIFICITY; DRUG TOLERANCE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BUPROPION; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SELF ADMINISTRATION; SMOKING; SMOKING CESSATION; SUCROSE;

EID: 30844464115     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200500381384     Document Type: Article

References (30)

1. Anderson, J. W. and Greenway, F. L. and Fujioka, K. and Gadde, K. M. and McKenney, J. and O'Neil, P. M. (2002) Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial. Obesity Research, 10, pp. 633 - 641.
2. Ascher, J. A. and Cole, J. O. and Colin, J. N. and Feighner, J. P. and Ferris, R. M. and Fibiger, H. C. and Golden, R. N. and Martin, P. and Potter, W. Z. and Richelson, E. and Sulser, F. (1995) Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, pp. 395 - 401.
3. Bardo, M. T. and Green, T. A. and Crooks, P. A. and Dwoskin, L. P. (1999) Nornicotine is self-administered intravenously by rats. Psychopharmacology, 146, pp. 290 - 296.
4. Bondarev, M. L. and Bondareva, T. S. and Young, R. and Glennon, R. A. (2003) Behavioral and biochemical investigations of bupropion metabolites. European Journal of Pharmacology, 474, pp. 85 - 93.
5. Bruijzeel, A. W. and Markou, A. (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse, 50, pp. 20 - 28.
6. Cooper, B. R. and Wang, C. M. and Cox, R. F. and Norton, R. and Shea, V. and Ferris, R. M. (1994) Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin®) are mediated by a noradrenergic mechanism. Neuropsychopharmacology, 11, pp. 133 - 141.
7. Cryan, J. F. and Bruijnzeel, A. W. and Skjei, K. L. and Markou, A. (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology, 168, pp. 1445 - 1447.
8. Damaj, M. I. and Carroll, F. I. and Eaton, J. B. and Navarro, H. A. and Blough, B. E. and Mirza, S. and Lukas, R. J. and Martin, B. R. (2004) Enantioselective effects of hydroxyl metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Molecular Pharmacology, 66, pp. 675 - 682.
9. Donny, E. C. and Caggiula, A. R. and Knopf, S. and Brown, C. (1995) Nicotine self-administration in rats. Psychopharmacology, pp. 122, 390 - 394.
10. Fava, M. (2000) Weight gain and antidepressants. Journal of Clinical Psychiatry, 61, pp. 37 - 41.
11. Ferris, R. M. and Cooper, B. R. and Maxwell, R. A. (1983) Studies of bupropion's mechanism of antidepressant activity. Journal of Clinical Psychiatry, 44, pp. 74 - 78.
12. Fryer, J. D. and Lukas, R. J. (1999) Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine and ibogaine. Journal of Pharmacology and Experimental Therapeutics, 288, pp. 88 - 92.
13. Glick, S. D. and Maisonneuve, I. M. and Kitchen, B. A. (2002) Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors. European Journal of Pharmacology, 448, pp. 185 - 191. 185-191
14. Hays, J. T. and Hurt, R. D. and Rigotti, N. A. and Niaura, R. and Gonzales, D. and Durcan, M. J. and Sachs, D. P. L. and Wolter, T. D. and Buist, A. S. and Johnston, J. A. and White, J. D. (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Annals of Internal Medicine, 35, pp. 423 - 433.
15. Hurt, R. D. and Sachs, D. P. L. and Glover, P. N. and Sullivan, C. R. and Croghan, I. T. and Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, pp. 1195 - 1202.
16. Jain, A. K. and Kaplan, R. A. and Gadde, K. M. and Wadden, T. A. and Allison, D. B. and Brewer, E. R. and Leadbetter, R. A. and Haight, R. N. and Jamerson, B. D. and Buaron, K. S. and Metz, A. (2002) Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms. Obesity Research, 10, pp. 1049 - 1056.
17. Jorenby, D. E. and Leischow, S. J. and Nides, M. A. and Rennard, S. I. and Johnston, J. A. and Hughes, A. R. and Smith, S. S. and Muramoto, M. L. and Daughton, D. M. and Doan, K. and Fiore, M. C. and Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine, 340, pp. 685 - 691.
18. Maisonneuve, I. M. and Glick, S. D. (2003) Anti-addictive actions of an iboga alkaloid congener: A novel mechanism for a novel treatment. Pharmacology, Biochemistry, and Behavior, 75, pp. 607 - 618.
19. Martin, P. and Massol, J. and Colin, J. N. and Lacomblez, L. and Puech, A. J. (1990) Antidepressant profile of bupropion and three metabolites in mice. Pharmacopsychiatry, 23, pp. 187 - 194.
20. Miller, D. K. and Sumithran, S. P. and Dwoskin, L. P. (2002) Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine. Journal of Pharmacology and Experimental Therapeutics, 302, pp. 1113 - 1122.
21. Phillips, G. and Willner, P. and Sampson, D. and Nunn, J. and Muscat, R. (1991) Time-, schedule- and reinforcer-dependent effects of pimozide and amphetamine. Psychopharmacology 104 pp.125-131
22. Rauhut, A. S. and Neugebauer, N. and Dwoskin, L. P. and Bardo, M. T. (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology, 169, pp. 1 - 9.
23. Shanks, N. and Anisman, H. (1989) Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology, 99, pp. 122 - 128.
24. Shoaib, M. and Sidhpura, N. and Shafait, S. (2003) Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology, 165, pp. 405 - 412.
25. Slemmer, J. E. and Martin, B. R. and Damaj, M. I. (2000) Bupropion is a nicotine antagonist. Journal of Pharmacology and Experimental Therapeutics, 295, pp. 321 - 327.
26. Suckow, R. F. and Smith, T. M. and Perumal, A. S. and Cooper, T. B. (1986) Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice and guinea pigs. Drug Metabolism and Discovery, 14, pp. 692 - 697.
27. Watkins, S. S. and Epping-Jordan, M. P. and Koob, G. F. and Markou, A. (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacology, Biochemistry, and Behavior, 62, pp. 743 - 751.
28. Wiley, J. L. and Lavecchia, K. L. and Martin, B. R. and Damaj, M. I. (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental and Clinical Psychopharmacology, 10, pp. 129 - 135.
29. Young, R. and Glennon, R. A. (2002) Nicotine and bupropion share a similar discriminative stimulus effect. European Journal of Pharmacology, 443, pp. 113 - 118.
30. Zarrindast, M. R. and Hosseini-Nia, T. (1988) Anorectic and behavioral effects of bupropion. General Pharmacology, 19, pp. 201 - 204.